Zobrazeno 1 - 10
of 18
pro vyhledávání: '"A. E. Ferrant"'
Autor:
E. Bourbon, K. Chabane, A.-S. Michallet, E. Ferrant, I. Mosnier, S. Poulain, M. Giraud, A. Bouvard, H. Ghesquieres, S. Hayette, P. Sujobert, S. Huet
Publikováno v:
HemaSphere, Vol 6, Pp 510-511 (2022)
Externí odkaz:
https://doaj.org/article/655fcc1ba4c945c9b649d6c6ea8961ec
Autor:
J. P. Sharman, M. Egyed, W. Jurczak, A. Skarbnik, K. Patel, I. W. Flinn, M. Kamdar, T. Munir, R. Walewska, L. M. Fogliatto, Y. Herishanu, V. Banerji, G. Follows, P. Walker, K. Karlsson, P. Ghia, A. Janssens, F. Cymbalista, E. Ferrant, W. G. Wierda, V. Munugalavadla, T. Yu, M. H. Wang, J. A. Woyach
Publikováno v:
HemaSphere, Vol 6, Pp 564-565 (2022)
Externí odkaz:
https://doaj.org/article/6c243e9771394497b143b0646ec5d63b
Autor:
E. Ferrant, Denis Caillot, L. Estivalet, C. Legouge, Pierre-Benoit Pagès, S. Valot, H. Abou Hanna, A. Plocque, Marie-Lorraine Chretien, F. Dalle, Ingrid Lafon
Publikováno v:
Revue des Maladies Respiratoires. 35:452-464
Resume Introduction La survenue d’une mucormycose pulmonaire (MP), dont l’incidence augmente au cours des aplasies chimio-induites des leucemies aigues (LA), reste une complication redoutable. Methodes Analyse des caracteristiques clinico-biologi
Autor:
E. Ferrant, E. Frobert, Florence Ader, Gilles Salles, E. Hodille, V. Safar, E. Neyret, Emmanuel Bachy, P. Sesques
Publikováno v:
Médecine et Maladies Infectieuses. 50:S120-S121
Introduction L’infusion de CAR T cells est un traitement innovant des hemopathies malignes B (lymphomes B diffus a grandes cellules [LBDGC], lymphomes indolents transformes [trL], leucemies aigues lymphoides B [LAL-B]). Une chimiotherapie lymphodep
Autor:
Xavier Pivot, Gilles Romieu, Marc Debled, Jean-Yves Pierga, Pierre Kerbrat, Thomas Bachelot, Alain Lortholary, Marc Espié, Pierre Fumoleau, Daniel Serin, Jean-Philippe Jacquin, Christelle Jouannaud, Maria Rios, Sophie Abadie-Lacourtoisie, Laurence Venat-Bouvet, Laurent Cany, Stéphanie Catala, David Khayat, Laetitia Gambotti, Iris Pauporté, Celine Faure-Mercier, Sophie Paget-Bailly, Julie Henriques, Jean Marie Grouin, C Piprot, L Cals, L Chaigneau, F Demarchi, T N'Guyen, U Stein, C Villanueva, JL Bréau, AK Chouahnia, P Saintigny, F Boué, P deSaint-Hilaire, I Guimont, N Grossat, B Valenza, E Lévy, J Médioni, C Delbaldo, J Grenier, D Pouessel, S Lavau-Denès, C Falandry, C Fournel-Fédérico, G Freyer, S Tartas, V Trillet-Lenoir, F Bons, G Auclerc, S Chièze, N Raban, C Tournigand, S Trager-Maury, G Bousquet, C Cuvier, S Giacchetti, A Hocini, C LeMaignan, JL Misset, D Avenin, C Beerblock, J Gligorov, P Rivera, H Roché, P Bougnoux, N Hajjaji, O Capitain, R Delva, P Maillart, P Soulié, H Bonnefoi, M Durand, N Madranges, L Mauriac, P Chollet, AF Dillies, X Durando, JP Ferrière, C Mouret-Reynier, JM Nabholtz, I Van Praagh, P Cottu, V Diéras, A Durieux, M Galotte, V Girre, S Henry, I Iurisci, M Jouve, V Laurence, L Mignot, S Piperno-Neumann, P Tresca, B Coudert, E Ferrant, F Mayer, AC Vanneuville, J Bonneterre, V Servent, L Vanlemmens, P Vennin, JP Guastalla, P Biron, L Dupuy-Brousseau, L Lancry, I Ray-Coquard, P Rebattu, O Trédan, JM Extra, F Rousseau, C Tarpin, M Fabbro, E Luporsi, L Uwer, B Weber, D Berton-Rigaud, E Bourbouloux, M Campone, JM Ferrero, P Follana, R Largillier, V Mari, B Costa, H Curé, JC Eymard, N Jovenin, D Lebrun, J Meunier, G Yazbek, D Gedoin, B Laguerre, C Lefeuvre, E Vauléon, A Chevrier, C Guillemet, M Leheurteur, O Rigal, I Tennevet, C Veyret, E Brain, M Guiterrez, F Mefti-Lacheraf, T Petit, F Dalenc, L Gladieff, F André, S Delaloge, J Domont, J Ezenfis, M Spielmann, P Guillet, V Boulanger, J Provençal, L Stefani, C Alliot, D Ré, C Bellaiche-Miccio, G Boutan-Laroze, R Vanica, P Dion, G Sadki-Benaoudia, A Marti, AL Villing, B Slama, JL Dutel, S Nguyen, R Saad, O Arsène, Z Merad-Boudia, H Orfeuvre, J Egreteau, MJ Goudier, R Lamy, B Leduc, C Sarda, B Salles, C Agostini, I Cauvin, A Dufresne, M Mangold, S Lebouvier-Sadot, B Audhuy, JC Barats, S Cluet-Dennetière, D Zylberait, G Netter, L Gautier-Felizot, I Cojean-Zelek, A Plantade, S Vignot, E Guardiola, P Marti, I deHartingh, R Diab, A Dietmann, S Ruck, C Portois, S Oddou-Lagranière, F Campos-Gazeau, A Bourcier, F Priou, JF Geay, D Mayeur, P Gabez, R ElAmarti, M Combe, P Raichon-Patru, P Amsalhem, J Dauba, D Paraiso, F Guinet, B Duvert, M Litor, F Kara-Slimane, A Bichoffe, N Denizon, P Soyer, F Morvan, S Van-Hulst, L Vincent, C Alleaume, P Ibanez-Martin, A Youssef, Z Tadrist, E Carola, C Pourny, JF Toccanier, N Al-Aukla, K Mahour-Bacha, J Salvat, P Nouyrigat, S Clippe, MC Gouttebel, L Vedrine, G Clavreul, O Collard, D Mille, Y Goubely, R Hervé, S Kirscher, F Plat, V Delecroix, V Ligeza-Poisson, D Coeffic, D Fric, C Garnier, C Leyronnas, T Kreitman, E Teissier, P Martin, S Rohart deCordoue, C ElKouri, JF Ramée, C Laporte, O Bernard, T Altwegg, A Darut-Jouve, JP Dujols, F Darloy, C Giraud, V Pottier-Kyndt, N Achour, S Drony, M Moriceau, C Sarrazin, JC Legueul, J Mandet, D Besson, AC Hardy-Bessard, J Cretin, P Houyau, E Achille, D Genêt, H Thévenot, A Moran-Ribon, JM Pavlovitch, P Ardisson, I Moullet, B Couderc, V Fichet, F Burki, A Auliard, CB Levaché, P Cailleux, F Schaeffer, N Albin, D Sévin-Robiche, J Domas, S Ellis, P Montcuquet, GA Baumont, M Bégue, S Gréget, JL Ratoanina, A Vanoli, C Bielsa, M Bonichon-Lamichhane, D Jaubert, H Laharie-Mineur, L Alcaraz, E Legouffe, H Bourgeois, G Cartron, F Denis, O Dupuis, G Ganem, S Roche-Forestier, L Delzenne, E Chirat, JL Baticle, E Béguier, S Jacquot, E Janssen, H Lauché, A LeRol, JP Chantelard, GA L'Helgoualc'h, EC Antoine, A Kanoui, JF Llory, JM Vannetzel, J Vignoud, C Bruna, T Facchini, K Moutel-Corviole, A Voloch, A Ghoul, D Loiseau, N Barbet, N Dohollou, K Yakendji
Publikováno v:
Lancet (London, England). 393(10191)
Summary Background In 2013, the interim analysis of the Protocol for Herceptin as Adjuvant therapy with Reduced Exposure (PHARE) trial could not show that 6 months of adjuvant trastuzumab was non-inferior to 12 months. Here, we report the planned fin
Autor:
M Tavernier, P Delaby, E. Ferrant, A Brion, D Caillot, H Andreux, M Heczcko, Ingrid Lafon, S. Limat, J. Fontan, C Malugani, E Prunier, Etienne Daguindau, P Helias, Fabienne Pouthier, Caroline Legouge, F Larosa, E Deconinck
Publikováno v:
Journal of Hematology And Oncology Research. 1:1-10
Autor:
L. Estivalet, C. Legouge, P.-B. Pagès, Jean Noel Bastie, A. Plocque, C. Favennec, Frédéric Dalle, E. Bottolier-Lemallaz, Marie-Lorraine Chretien, A. Bernard, Ingrid Lafon, E. Ferrant, Denis Caillot
Publikováno v:
Clinical Microbiology and Infection
Clinical Microbiology and Infection, Wiley, 2016, 22 (9), pp.782-787. 〈10.1016/j.cmi.2015.12.029〉
Clinical Microbiology and Infection, Wiley, 2016, 22 (9), pp.782-787. 〈10.1016/j.cmi.2015.12.029〉
International audience; Invasive fungal infections (IFI) remain life-threatening complications in haematological patients. The aim of the study was to present the experience of a single centre in the surgical treatment of pulmonary IFI. Between 1992
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a54d2adc790dfce932cf5df353bd53ac
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01427633
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01427633
Autor:
D, Caillot, C, Legouge, I, Lafon, E, Ferrant, P B, Pagès, A, Plocque, L, Estivalet, S, Valot, F, Dalle, H, Abou Hanna, M-L, Chretien
Publikováno v:
Revue des maladies respiratoires. 35(4)
In acute leukaemia (AL), the occurrence of pulmonary mucormycosis (PM), the incidence of which is increasing, as a result of chemotherapy induced marrow aplasia, remains a life threatening complication.Analysis of clinical, biological and thoracic CT
Autor:
Frédéric Dalle, S. Audia, L. Martin, Ingrid Lafon, C. Legouge, P.-B. Pagès, M. Roques, E. Ferrant, Denis Caillot, T. Maitre, Marie-Lorraine Chretien, Jean Noel Bastie, L. Estivalet
Publikováno v:
Clinical Infectious Diseases
Clinical Infectious Diseases, Oxford University Press (OUP), 2014, 58 (5), pp.672-678. ⟨10.1093/cid/cit929⟩
Clinical Infectious Diseases, Oxford University Press (OUP), 2014, 58 (5), pp.672-678. ⟨10.1093/cid/cit929⟩
Background Pulmonary mucormycosis (PM) is a life-threatening fungal infection with an increasing incidence among patients with acute leukemia. In some immunocompromised hosts, the reversed halo sign (RHS) has been described on the pulmonary computed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb62de6a3877f12c09b94086b6a2b570
https://hal.inrae.fr/hal-02640036
https://hal.inrae.fr/hal-02640036
Autor:
Jean Noel Bastie, Ingrid Lafon, K. Astruc, Marc Sautour, E. Ferrant, Denis Caillot, Serge Aho, B. Cuisenier, Frédéric Dalle
Publikováno v:
Journal de Mycologie Médicale
Congress of the French Society of Medical Mycology (SFMM)
Congress of the French Society of Medical Mycology (SFMM), Société Française de Mycologie Médicale (SFMM). FRA., May 2013, Dijon, France. ⟨10.1016/j.mycmed.2013.07.028⟩
Congress of the French Society of Medical Mycology (SFMM)
Congress of the French Society of Medical Mycology (SFMM), Société Française de Mycologie Médicale (SFMM). FRA., May 2013, Dijon, France. ⟨10.1016/j.mycmed.2013.07.028⟩